Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012-2017).
kidney transplant candidate
pretransplant screening
strongyloidiasis
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
01 Jul 2019
01 Jul 2019
Historique:
received:
14
02
2019
accepted:
11
04
2019
entrez:
1
8
2019
pubmed:
1
8
2019
medline:
1
8
2019
Statut:
ppublish
Résumé
Disseminated strongyloidiasis in solid organ transplant recipients is a rare but devastating infection. In our center, we implemented a universal screening of all candidates for kidney transplantation. We assessed the seroprevalence and utility of universal screening for strongyloidiasis in our center. Patients were identified from our transplant referral list (from July 2012 to June 2017). Demographics, pretransplant laboratory, and serological screenings were retrospectively collected. For Strongyloides-seropositive (SSp) patients, data on travel history, symptoms, treatment, and stool ova and parasite examinations were extracted. Logistic regression and multiple imputation for missing data were performed. A total of 1689 patients underwent serological screening, of whom 168 (9.9%) were SSp. Univariate analysis revealed that SSp patients had higher rates of eosinophilia, diabetes mellitus, latent tuberculosis and were likely to be either Hispanic or Asian (P < .05). In multivariate analysis, eosinophilia (P = .01), diabetes mellitus (P = .02), and Asian race (P = .03) were associated with being SSp, but 45 (27%) of the SSp patients did not have any of these 3 factors, and 18 SSp patients (11%) had no epidemiological risk factors. All patients received ivermectin, and none developed disseminated strongyloidiasis. Of patients who underwent serological screening on multiple occasions, 6.8% seroconverted while waiting for kidney transplantation. We found a high rate of Strongyloides seropositivity among our kidney transplantation candidates. No epidemiological risk factors effectively predicted SSp status in our population, and universal screening identified a large number of patients without such factors. Serial screening should be considered when a long wait time is expected before transplantation.
Sections du résumé
BACKGROUND
BACKGROUND
Disseminated strongyloidiasis in solid organ transplant recipients is a rare but devastating infection. In our center, we implemented a universal screening of all candidates for kidney transplantation. We assessed the seroprevalence and utility of universal screening for strongyloidiasis in our center.
METHODS
METHODS
Patients were identified from our transplant referral list (from July 2012 to June 2017). Demographics, pretransplant laboratory, and serological screenings were retrospectively collected. For Strongyloides-seropositive (SSp) patients, data on travel history, symptoms, treatment, and stool ova and parasite examinations were extracted. Logistic regression and multiple imputation for missing data were performed.
RESULTS
RESULTS
A total of 1689 patients underwent serological screening, of whom 168 (9.9%) were SSp. Univariate analysis revealed that SSp patients had higher rates of eosinophilia, diabetes mellitus, latent tuberculosis and were likely to be either Hispanic or Asian (P < .05). In multivariate analysis, eosinophilia (P = .01), diabetes mellitus (P = .02), and Asian race (P = .03) were associated with being SSp, but 45 (27%) of the SSp patients did not have any of these 3 factors, and 18 SSp patients (11%) had no epidemiological risk factors. All patients received ivermectin, and none developed disseminated strongyloidiasis. Of patients who underwent serological screening on multiple occasions, 6.8% seroconverted while waiting for kidney transplantation.
CONCLUSIONS
CONCLUSIONS
We found a high rate of Strongyloides seropositivity among our kidney transplantation candidates. No epidemiological risk factors effectively predicted SSp status in our population, and universal screening identified a large number of patients without such factors. Serial screening should be considered when a long wait time is expected before transplantation.
Identifiants
pubmed: 31363770
pii: 5452022
doi: 10.1093/ofid/ofz172
pmc: PMC6656655
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
South Med J. 1999 Jul;92(7):728-31
pubmed: 10414486
Mem Inst Oswaldo Cruz. 2002 Jan;97(1):119-21
pubmed: 11992161
Am J Trop Med Hyg. 2002 Jun;66(6):749-52
pubmed: 12224585
Expert Opin Pharmacother. 2004 Dec;5(12):2615-9
pubmed: 15571478
Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):14-8
pubmed: 16418832
J Travel Med. 2006 Mar-Apr;13(2):84-91
pubmed: 16553594
Acta Trop. 2006 Aug;99(1):102-5
pubmed: 16872576
J Clin Microbiol. 2007 Feb;45(2):438-42
pubmed: 17151215
Transpl Infect Dis. 2008 Apr;10(2):137-41
pubmed: 17605735
Clin Infect Dis. 2009 Nov 1;49(9):1411-23
pubmed: 19807271
Am J Transplant. 2009 Nov;9(11):2637-40
pubmed: 19843038
Transplantation. 2011 May 15;91(9):1019-24
pubmed: 21358367
Emerg Infect Dis. 2011 May;17(5):931-2
pubmed: 21529417
Am J Transplant. 2013 Mar;13 Suppl 4:9-21
pubmed: 23464994
Am J Transplant. 2013 Mar;13 Suppl 4:280-303
pubmed: 23465021
Am J Trop Med Hyg. 2013 Jun;88(6):1041-7
pubmed: 23509117
PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2288
pubmed: 23875033
Can J Infect Dis Med Microbiol. 2013 Summer;24(2):93-6
pubmed: 24421809
PLoS Negl Trop Dis. 2014 Jan 09;8(1):e2640
pubmed: 24427320
Clin Microbiol Infect. 2014 Sep;20 Suppl 7:10-8
pubmed: 24476053
Am J Trop Med Hyg. 2014 May;90(5):830-4
pubmed: 24615124
Am J Transplant. 2014 May;14(5):1003-11
pubmed: 24636427
Am J Trop Med Hyg. 2014 Nov;91(5):1000-1
pubmed: 25157122
Diabetes Res Clin Pract. 2015 Mar;107(3):355-61
pubmed: 25656764
Am J Transplant. 2015 May;15(5):1369-75
pubmed: 25703251
Clin Microbiol Infect. 2015 Jun;21(6):543-52
pubmed: 25887711
Cochrane Database Syst Rev. 2016 Jan 18;(1):CD007745
pubmed: 26778150
Am J Case Rep. 2017 Apr 03;18:339-346
pubmed: 28366929
N Engl J Med. 1989 Jan 26;320(4):252-3
pubmed: 2911314
Clin Infect Dis. 2018 May 2;66(10):1558-1565
pubmed: 29360939
PLoS Negl Trop Dis. 2018 Feb 9;12(2):e0006229
pubmed: 29425193
Clin Infect Dis. 2018 Aug 16;67(5):810-811
pubmed: 29788131
Infect Dis Clin North Am. 2018 Sep;32(3):749-763
pubmed: 30146034
Clin Transplant. 2019 Apr;33(4):e13497
pubmed: 30773692
Am J Trop Med Hyg. 1995 Sep;53(3):248-50
pubmed: 7573706